Symbols

EW

Edwards Lifesciences·NYSE

--(--)

Market Open: --

--(--)

Pre-Market: --

Signals Analysis

Bullish signal 5

Bearish signal 2

Consensus Rating "Strong Buy"

Ample Liquidity

High Gross Profit Margin

Significant Net Income Decline

High Cash/net Profit Ratio

Revenue Beats Expectation

EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About EW

Edwards Lifesciences Corporation

A global leader of patient-focused innovations for structural heart disease and critical care monitoring

Industry

Healthcare Equipment and Supplies

Established Date

09/10/1999

Listing Date

04/03/2000

Exchange

New York Stock Exchange

Full-time Employees

15,800

Fiscal Year Ends

12-31

Website

www.edwards.com

Security Type

Common stock

Office address

One Edwards Way, Irvine, California 92614

Business

Development and commercialization of heart valve therapies and devices

Introduction

Edwards Lifesciences Corporation was incorporated in Delaware on September 10, 1999. The company is a global leader in structural heart disease and intensive care and surgical care. Driven by a passion to help patients, the company partners with the world's leading clinicians and researchers to invest in research and development to transform the care of patients with structural heart disease, or those who require hemodynamic monitoring during surgery or intensive care.

Earnings Call

Q2/2025

Estimate EPS0.62

Actual EPS0.67

Estimate Revenue1.49B

Actual Revenue1.53B

Edwards Lifesciences Q2 2025: Contradictions in TAVR Performance, CMS Expectations, and Growth Guidance

Jul 24,2025 11:19·
Earnings Decrypt

Company Financials

EPS

EW has released its 2025 Q3 earnings. EPS was reported at 0.67, versus the expected 0.59, beating expectations. The chart below visualizes how EW has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

EW has released its 2025 Q3 earnings report, with revenue of 1.55B, reflecting a YoY change of 14.67%, and net profit of 290.30M, showing a YoY change of -90.54%. The Sankey diagram below clearly presents EW's revenue sources and cost distribution.